FREQUENCY OF H. PYLORI INFECTION IN PERFORATED PEPTIC ULCER PATIENTS

Main Article Content

Tayyeb Ullah
Suliman Shah
Haider Ali
Muhammad Marwan
Sidra Jabeen
Khalid Habib

Keywords

H. pylori, Perforated peptic ulcer, Common medical problem

Abstract

Introduction: Peptic ulcer disease is a common medical problem with a lifetime prevalence of 5-10% and an incidence of 1.5-3% in general population per year.


Objective: To determine the occurrence of H. Pylori infection in patients with perforated peptic ulcer.


Setting: Department of Surgery, Lady Reading Hospital, Peshawar, Pakistan


Study design: Cross sectional Study.


Duration of study: Six months from 4th August 2020 to 4th February, 2021.


Materials and methods: In the current study a total of 171 patients were observed. Data like patient age, sex, history of Non-steroid anti-inflammatory drugs usage in last 10 days and history of peptic ulcer disease was noted. Patients were managed and were prepared for surgical intervention as per protocol. During surgery the biopsy from perforation site was taken and was sent for culture & sensitivity. IBM-SPSS Version.23 was used for analysis of data.


Results: In the current study, a total of 171 patients were enrolled. In our study, 150(87.72%) patients were male and 21(12.28%) patients were female. 79(46.2%) patients had positive history of NSAID usage and 92(53.8%) patients had negative history of NSAID usage. 93(54.4%) patients had helicobacter pylori infection and 78(45.6%) patients didn’t had helicobacter pylori infection.


Conclusion: Our study concludes that the frequency of H. pylori infection was 54.4% in perforated peptic ulcer patients.

Abstract 165 | Pdf Downloads 40

References

1. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613-24.
2. Chung KT, Shelat VG. Perforated peptic ulcer - an update. World J Gastrointest Surg. 2017;9(1):1–12.
3. Leow AR, Lim YY, Liew WC, Goh KL. Time trends in upper gastrointestinal diseases and Helicobacter pylori infection in a multiracial Asian population–a 20‐year experience over three time periods. Aliment Pharmacol Ther. 2016;43(7):831-7.
4. Malmi H, Kautiainen H, Virta LJ, Färkkilä N, Koskenpato J, Färkkilä MA. Incidence and complications of peptic ulcer disease requiring hospitalisation have markedly decreased in Finland. Aliment Pharmacol Ther. 2014;39(5):496-506.
5. Søreide K, Thorsen K, Harrison EM, Bingener J, Møller MH, Ohene-Yeboah M, et al. Perforated peptic ulcer. Lancet. 2015;386(10000):1288-98.
6. Malmi H. Peptic ulcer disease: incidence, associated morbidity and mortality. Helsinki: [H. Malmi], 2018. 90-1
7. Rehmani B, Pathak P. The prevalence of Helicobacter pylori in perforated peptic ulcer disease. Intern Surg J. 2018;5(5):1720-3.
8. John B, Mathew BP, Chandran V. Prevalence of Helicobacter pylori in peptic ulcer perforation. Intern Surg J. 2017;4(10):3350-3.
9. Gisbert JP, Legido J, Garcı́a-Sanz I, Pajares JM. Helicobacter pylori and perforated peptic ulcer. Prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2004;36(2):116-20.
10. Magsi AM, Iqbal M, Malik M, Parveen S. Silent peptic ulcer disease perforation. J Surg Pak. 2017;22:2.
11. Rehmani B, Pathak P. The prevalence of Helicobacter pylori in perforated peptic ulcer disease. Intern Surg J. 2018;5(5):1720-3.
12. John B, Mathew BP, Chandran V. Prevalence of Helicobacter pylori in peptic ulcer perforation. Intern Surg J. 2017;4(10):3350-3.
13. Gisbert JP, Legido J, Garcı́a-Sanz I, Pajares JM. Helicobacter pylori and perforated peptic ulcer. Prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2004;36(2):116-20.
14. Magsi AM, Iqbal M, Malik M, Parveen S. Silent peptic ulcer disease perforation. J Surg Pak. 2017;22:2.
15. Kumar D, Sinha AN. Helicobacter pylori infection delays ulcer healing in patients operated on for perforated duodenal ulcer. Indian J Gastroenterol. 2002;21(1):19-22.
16. Chowdhary SK, Bhasin DK, Panigrahi D, Malik AK, Katria RN. Helicobacter pylori Infection in patients with perforated duodenal ulcer. Tropical Gastroenterol. 1998;19:19-21.
17. Reinbach DH, Cruickshank G, McColl KE. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut. 1993;34(10):1344-7.
18. Sakaguchi M, Oka H, Amemoto K, Honda M, Nakajima F, Kibi S, et al. Clinical investigation of perforated duodenal ulcer-with special reference to the presence of Helicobacter pylori infection and rate of recurrence. Nihon Shokakibyo Gakkai Zasshi. 2002;90(10):1197-204.
19. Debongnie JC, Wibin E, Timmermans M, Mairesse J, Dekoninck X. Are perforated gastroduodenal ulcers related to Helicobacter pylori infection. Acta Gastroenterol Belg. 1995;58(2):208-12.
20. Ng EK, Chung SC, Sung JJ, Lam YH, Lee DW, Lau JY et al. High prevalence of Helicobacter pylori infection in duodenal ulcer perforations not caused by non-steroidal anti-inflammatory drugs. Br J Surg. 1996; 83(12):1779-81.
21. Aman Z, Naeem M, Khan RM, Ahmad T, Alam M, Noreen S et al. Pattern of change in the frequency of Helicobacter pylori with perforated duodenal ulcer. J Ayub Med Coll Abbottobad. 2008; 20(4):41-3.
22. Sharma AK, Mittal S, Malvi SK. Association of Helicobacter pylori with peptic perforation in Chattisgarh region of India. Trop Gastroenterol. 2000;21(1):42-3.
23. Gisbert JP, Legido J, Garcia-Sans, Pajares JM. Helicobacter pylori and perforated peptic ulcer prevalence of the information and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2004;36(2):116-20.
24. Kumar D, Sinha AN. Helicobacter pylori infection delays ulcer healing in patients operated on for perforated duodenal ulcer. Indian J Gastroenterol. 2002;21(1):19-22.
25. Bose AC, Kate B, Ananthakrishnan N, Parija SC. Helicobacter pylori eradication prevents recurrence after simple closure of perforated duodenal ulcer. J Gastroenterol Hepatol. 2007;22(3):345-8